WATCH: Detecting autism at Birth and Opportunity for Early Intervention
Detecting autism at Birth and Opportunity for Early Intervention: Manish Arora, PhD, Founder, CEO and CSO at Linus Bio, speaks at the Institute for Exposomic Research at Mount Sinai.
Keep readingWATCH: HITLAB 2021 Innovator’s Summit Presentation
Manish Arora, PHD, Co-Founder of Linus Biotechnology speaks at HITLAB 2021 Innovator’s Summit Presentation
Keep readingLinus Biotechnology Inc. Receives FDA Breakthrough Device Designation for StrandDx™-ASD Exposome Sequencing Diagnostic
Linus Biotechnology Inc., a leader in precision exposome sequencing, today announced that the U.S. Food and Drug Administration Center for Devices and Radiological Health has granted the Company’s StrandDx™-ASD diagnostic aid the designation as a Breakthrough Device for Autism Spectrum Disorder (ASD)
Keep readingMount Sinai Spin-Off Linus Biotechnology Inc. to Revolutionize Precision Medicine with Exposome Sequencing
LinusBio is a novel biotechnology company dedicated to developing and commercializing molecular exposome and biological-response sequencing for complex diseases for which genomic sequencing alone cannot sufficiently characterize underlying biological disease pathways
Keep reading